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formed by both lipid and sugar oxidative degradation 
pathways [10]. 
 Similarly to their chemical heterogeneity and complexity, 
AGEs and ALEs exert their biological (damaging) acti-
vity through diﬀ erent and in some cases as yet not 
well-deﬁ ned mechanisms. Some of the biological eﬀ ects 
are due to the loss of function of the target proteins under-
going the covalent modiﬁ cation, such as in the case of 
extracellular matrix proteins that lose their elastic and 
mechanical functions when modiﬁ ed as AGEs/ALEs and 
in particular, when cross-links are involved [11]. Other 
examples of a direct damaging eﬀ ect of AGEs/ALEs can 
be ascribed to the covalent modiﬁ cation of enzymes and 
receptors that lose their activity due to the covalent 
modiﬁ cation involving the catalytic or binding site, or 
following a conformational change of the protein struc-
ture. AGEs and ALEs are also immunogenic and have 
been shown to elicit antibodies in a variety of diseases 
including systemic lupus erythematosus, alcoholic liver 
disease, diabetes mellitus, and rheumatoid arthritis as 
reviewed by Kurien et  al. [12] 
 AGEs also exert their damaging and pro-inﬂ ammatory 
eﬀ ects by activating signaling cascades via speciﬁ c 
receptors named RAGE (receptor for AGEs) [13]. There 
are several other receptors for AGEs including P60/
OST-48 protein (AGE-Rl), 80 K-H phosphoprotein 
(AGE-R2), galectin (AGE-R3) [14]. It is still not 
clear whether the damaging eﬀ ect of ALEs includes a 
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 Advanced lipoxidation end products (ALEs) and advanced glycation end products (AGEs) have a pathogenetic role in the development and 
progression of diﬀ erent oxidative-based diseases including diabetes, atherosclerosis, and neurological disorders. AGEs and ALEs represent 
a quite complex class of compounds that are formed by diﬀ erent mechanisms, by heterogeneous precursors and that can be formed either 
exogenously or endogenously. There is a wide interest in AGEs and ALEs involving diﬀ erent aspects of research which are essentially 
focused on set-up and application of analytical strategies (1) to identify, characterize, and quantify AGEs and ALEs in diﬀ erent pathophysi-
ological conditions; (2) to elucidate the molecular basis of their biological eﬀ ects; and (3) to discover compounds able to inhibit AGEs/
ALEs damaging eﬀ ects not only as biological tools aimed at validating AGEs/ALEs as drug target, but also as promising drugs. All the 
above-mentioned research stages require a clear picture of the chemical formation of AGEs/ALEs but this is not simple, due to the complex 
and heterogeneous pathways, involving diﬀ erent precursors and mechanisms. In view of this intricate scenario, the aim of the present review 
is to group the main AGEs and ALEs and to describe, for each of them, the precursors and mechanisms of formation. 
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 Introduction 
 Several studies indicate that advanced glycation end 
 products (AGEs) and advanced lipoxidation end products 
(ALEs) have a pathogenetic role in the development and 
progression of diﬀ erent oxidative-based diseases includ-
ing diabetes [1 – 3], chronic renal failure [4,5], cardiovas-
cular diseases [6,7] and neurological disorders [8,9]. 
 From a chemical point of view, AGEs and ALEs 
 represent a quite complex class of compounds that are 
formed by diﬀ erent mechanisms, by heterogeneous pre-
cursors and can be formed either exogenously or endog-
enously. In more detail, as better explained below, 
AGEs represent a class of covalently modiﬁ ed proteins 
generated by oxidative and non-oxidative pathways, 
involving sugars or their degradation products. The 
term ALEs includes a variety of covalent adducts which 
are generated by the nonenzymatic reaction of reactive 
carbonyl species (RCS), produced by lipid peroxidation 
and lipid metabolism, with the nucleophilic residues of 
macromolecules. AGEs and ALEs share some common 
properties, for example, both consist of nonenzymatic, 
covalently modiﬁ ed proteins and oxidative stress is 
often (although not always) involved in the mechanism 
of their formation. Moreover some AGEs and ALEs 
have the same structure, since they arise from com-
mon precursors, as in the case of carboxymethyllysine 
(CML) which is generated by glyoxal, which in turn is 
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receptor-mediated mechanism and in this case whether 
RAGE is involved. 
 The AGEs and ALEs ’ precursors share a common 
electrophilic nature, which determines their marked 
reactivity toward the nucleophilic centers in the biomac-
romolecules. Indeed and as described below, all the 
chemical pathways leading to ALEs and AGEs can 
roughly be seen as condensation reactions between 
nucleophilic and electrophilic reactants. As discussed by 
LoPachin, [15] these compounds cannot condense indis-
criminately, but they can react, provided that they have a 
similar polarizability, thus generating only well-deﬁ ned 
sets of covalent adducts. 
 The precursors of ALEs are generally lipophilic so they 
interact with the cell membrane components leading to 
disturbance of membrane integrity, seen as blebs forma-
tion [16]. Blebs are plasma membrane vesicles, often 
observed in apoptosis, formed when membrane domains 
(lipid rafts) are detached from cytoskeleton [17]. Yet blebs 
are active in systematic signaling during inﬂ ammation, 
contributing to the initiation and progression of chronic 
inﬂ ammatory processes in organisms, as they are released 
from the cell in the form of membrane vesicles [18]. 
 There is a wide interest in AGEs and ALEs involving 
diﬀ erent aspects of research, which are essentially focused 
on set-up and application of analytical strategies (1) to 
identify, characterize and quantify AGEs – ALEs in diﬀ er-
ent pathophysiological conditions; (2) to elucidate the 
molecular basis of their biological eﬀ ects; and (3) to dis-
cover compounds able to inhibit AGEs/ALEs damaging 
eﬀ ects not only as biological tools aimed at validating 
AGEs/ALEs as drug target, but also as promising drugs. 
 All the above-mentioned research stages require a 
detailed knowledge of the chemical formation of AGEs/
ALEs. As already mentioned, this is not simple, due to 
the complex and heterogeneous pathways, involving dif-
ferent precursors and mechanisms. In view of this intri-
cate scenario, the aim of the present review is to group 
the main AGEs and ALEs and to describe, for each of 
them, the precursors and mechanisms of formation. 
While recognizing that the electrophilic precursors can 
also react with nucleic acids and phospholipids, generat-
ing well-established covalent adducts, this review will 
be almost exclusively focused on the AGEs and ALEs 
formation involving protein nucleophilic centers. The 
interested reader can refer to specialized reviews for the 
adducts involving other biomolecules. (e.g. [19,20]). 
Moreover, the biological eﬀ ects and mechanism of 
AGEs and ALEs as well as the molecular strategies for 
their inhibition are not considered herein and for these 
aspects the reader can refer to the reviews published in 
this special issue or to some excellent reviews already 
published [21 – 23]. 
 AGEs: an introduction 
 The browning process, that occurs during food heating, 
is a well-known phenomenon which characterizes several 
cooked dishes and is caused by the so-called Maillard 
reaction, a nonenzymatic process ﬁ rstly described by 
Maillard in 1912 (Louis Camille Maillard, 1878 – 1936) 
[24]. It generates yellowish-brown colored products and 
involves a complex series of degradative reactions 
between sugars and proteins, whose chemical mecha-
nisms were ﬁ rst described by Hodge 40 years later [25]. 
For many years, studies on the Maillard reaction were 
focused on foods and food-like systems where it occurs 
during heating, processing, and storage, and plays key 
roles in determining color, ﬂ avor, and nutritional quality. 
Other studies concerned the eﬀ ects of the Maillard reac-
tion when it occurs in paper, textile, soil, and biopharma-
ceutical products. 
 Even though the ﬁ rst glycated protein was discovered 
by Kunkel and Wallenius in 1955 (a glycated HbA1C 
hemoglobin) [26], increasing attention has been shifted 
to the human body only in the last three decades, namely 
since the pathological role of  in vivo posttranslational 
protein glycation has become clearly evident in all its 
detrimental consequences.  In vivo , the process can occur 
in tissue and body ﬂ uids, is usually associated with 
hyperglycemic pathophysiological conditions, and 
involves the generation of irreversible protein adducts 
and cross-links known as AGEs. After the seminal stud-
ies of Monnier and Cerami [27], who postulated in the 
early 1980s that protein glycation could play a detrimen-
tal role in aging-related pathologies, a progressively 
more-detailed understanding of the individual reactions 
involved in AGEs generation has compellingly empha-
sized that their accumulation has clear pathophysiologi-
cal implications [28].  In vivo , several disorders appear 
to be exacerbated by such damaging protein adducts, 
especially when they involve long-lived proteins. A 
paradigmatic example is oﬀ ered by collagen [29], the 
glycation of which induces vascular thickening with 
detrimental consequences including decreased elastic-
ity, hypertension, and endothelial dysfunctions, and 
induces marked accelerating eﬀ ects on disorders such 
as atherosclerosis, nephropathy, and retinal pathologies 
[6,30,31]. Moreover, glycation can also aﬀ ect short-
lived peptides causing detrimental changes in their bio-
logical functions as demonstrated by the accumulation 
of glycated insulin in the pancreatic  β -cells of diabetic 
animal models [32]. 
 Without neglecting their biological implications, the 
following sections will be mainly devoted to chemical 
aspects of AGEs generation so as to play an introductory 
role for the other reviews in this special issue in which 
the therapeutic strategies, to reduce their formation  in 
vivo , will be comprehensively described. 
 Maillard reaction 
 As shown in Figure 1 and following the well-known 
Hodge ’ s scheme [25], the ﬁ rst step in the Maillard reac-
tion involves condensation between a carbonyl group 
from a reducing sugar (e.g. D-glucose ( 1.1 ) on which 
 Figure 1 is indeed focused) and a primary amino group 
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  AGEs and ALEs: mechanisms of formation  5
belonging, for example, to the lysine side chain or to the 
protein N-terminus. The condensation yields a car-
binolamine intermediate, which dehydrates to give an 
unstable imine adduct which can, in turn, cyclize to gen-
erate N-substituted D-glucosylamine ( 1.2 ) [33]. 
 At physiological pH and room temperature, the imine 
derivative spontaneously undergoes the acid-catalyzed 
Amadori rearrangement (Mario Amadori, 1886 – 1941) 
[33] and gives the corresponding N-substituted 1-amino-
2-desoxy-2-ketose ( 1.3 ), which can cyclize yielding 
derivatives called Amadori products which are more sta-
ble compared to that of the N-substituted D-glucosylam-
ine [34] even though all these products can react with 
amino acids to produce brown melanoidins [35]. It should 
be remembered that also nonreducing ketoses can undergo 
a similar set of reactions, which produce the correspond-
ing N-substituted 1-amino-2-desoxy-aldoses following 
the so-called Heyns rearrangement [36]. Formation of the 
Amadori products is favored at alkaline pH values and in 
the presence of phosphate ions. 
 Despite being relatively stable, the Amadori products 
can react following two major routes. At low pH values, 
they undergo enolization yielding 1,2-dicarbonyls, which 
then dehydrate to give furfural derivatives [37]. Furfural 
derivatives, among which 5-hydroxymethyl furfural ( 2.6 ) 
is the most common, are formed quite rapidly, and indeed 
are usually utilized as easily detectable markers to follow 
food deterioration during prolonged storage [38]. They 
quickly react with amino acids to yield brown melanoi-
dins even though furfurals are not the main precursors 
leading to them [39]. 
 At higher pH values, enolization produces 2,3-
dicarbonyls which then dehydrate to give reductones [40]. 
These conjugated enediols have a moderate reducing 
power and can contribute to antioxidant activity. In the 
presence of amino acids they can generate brown mel-
anoidins. The cyclization of 2,3 dicarbonyl intermediates 
can also give furanones and pyranones which include 
important ﬂ avor compounds with very low aroma thresh-
old values [41]. 
 By following diﬀ erent pathways, Amadori products 
can generate  α -dicarbonyls mainly through oxidative ﬁ s-
sion [42] or retro-aldol fragmentation [43], the former 
being markedly catalyzed by the presence of transition 
metal ions. Sugar fragmentation can also occur via a free 
radical-based mechanism according to the so-called 
Namiki pathway [44]. Dicarbonyl compounds are very 
reactive products and their critical relevance in AGEs 
generation will be discussed in-depth in this review. 
Besides dicarbonyls, sugar fragmentation can also gener-
ate hydroxyl aldehydes and the corresponding oxidized 
acid analogues as depicted in Figure 2. Dicarbonyl com-
pounds can react with amino acids through the so-called 
Strecker degradation, in which the amino acid is trans-
formed into the corresponding aldehyde liberating CO 2 
and the remaining  α -aminocarbonyl compound, which 
 Figure 1. Major steps in the Maillard reaction of reducing sugars following the well-known Hodge scheme. 
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can then condense to yield pyrazine derivatives, typical 
aroma components in heated foods [39]. 
 As shown in Figure 1, all generated carbonyl products 
can condense with primary amines (mainly coming from 
amino acids) to produce polymeric melanoidins. They are 
high molecular mass, brown-colored adducts whose pre-
cise structure is still to be fully elucidated even though it 
includes nitrogen-containing heterocycles [45]. Melanoi-
din formation increases with time and more markedly 
with temperature [46]. 
 The relationship between sugar structure and suscep-
tibility to Maillard reaction has been extensively studied 
both  in vivo and in foodstuﬀ s [47]. Although in all sug-
ars the cyclic form is thermodynamically favored, the 
reactivity of monosaccharides is directly related to the 
abundance of their open chain form, which ranges from 
0.0002% for glucose to 0.7% for fructose ( 6.2 ) [48]. 
This easily explains why glucose, due to the mentioned 
stability of its pyranose form, is the least reactive sugar, 
while fructose whose furanosic cyclic form is somewhat 
less stable is about 7.5-fold more reactive than glucose 
[49]. Notably, the Maillard reaction can also involve 
fructose metabolites, such as fructose-6-phosphate ( 4.2 ) 
or glyceraldehyde-3-phosphate ( 4.4 ), which show an 
extraordinary reactivity up to 200-fold compared to that 
of glucose. The resulting critical role of fructose in pro-
tein glycation leads to the term  “ fructosylation ” , and the 
fructose eﬀ ects are further exacerbated by its wide-
spread diﬀ usion [50,51]. Indeed, fructose is the most 
common naturally occurring monosaccharide in human 
diet mostly because of the high-fructose syrup produced 
by starch, which is usually added to beverages and baked 
foods [52]. Despite its low reactivity, even glucose, 
which is present in millimolar concentration in several 
tissues, markedly contributes to protein glycation also 
because it can be converted into fructose via the polyol 
pathway [52]. Besides the abundance of open chain 
forms, other factors governing susceptibility to the 
Maillard reaction include the sugar length and the 
intrinsic reactivity of the functional groups. Thus, 
aldoses are more reactive than ketoses, because alde-
hydes are more accessible and more electrophilic than 
ketones [48]. 
 Figure 2 illustrates some relevant players involved in 
the above-described Maillard reaction. The ﬁ rst row col-
lects the major  α -dicarbonyls including both short-chain 
derivatives (e.g. glyoxal,  2.1 , and methylglyoxal,  2.2 ) and 
longer polyol dicarbonyls (e.g. glucosone analogues,  2.4 
and  2.5 ). As mentioned before, the key role of dicarbonyls 
in AGEs formation will be discussed in-depth throughout 
the review. The second row shows the main cyclization 
products. Beside the already-mentioned 5-hydroxymethyl 
furfural ( 2.6 ), it is worth mentioning furaneol ( 2.7 , 2,5-
dimethyl-4-hydroxy-3(2H)-furanone) [53], which repre-
sents an illustrative example of reductones and is one of 
the most ﬂ avor active volatile compounds (caramel-
like odor) always present in the aroma extract from the 
Maillard reaction. Cyclization of 2,3-dicarbonyls can also 
aﬀ ord ﬂ avored and colored furanones (e.g. Maple fura-
none,  2.8 , 5-Ethyl-3-hydroxy-4-methyl-2(5H)-furanone) 
[54] and pyranones (maltol,  2.9 , 3-Hydroxy-2-methyl-4-
pyrone), this latter essentially generated by the decompo-
sition of disaccharides during caramelization [55]. Lastly, 
isomaltol ( 2.10 , 1-(3-hydroxy-2-furanyl)-ethanone) is 
another common example of furan derivatives resulting 
from the dehydration of 2,3-dicarbonyls which can be 
easily converted into the maltol analogue. It typically 
arises from Maillard degradation of lactose, even though 
it can be formed by the enzymatic degradation of starch, 
as well [56]. 
 The last row includes examples of hydroxyl carbonyl 
compounds arising from sugar fragmentation. They 
include aldehydes ( 2.11 – 2.13 ), ketones ( 2.14 and  2.15 ), 
and oxidized derivatives as in the case of levulinic 
acid (4-oxopentanoic acid,  2.16 ) which arises from the 
acid-catalyzed ring opening of the 5-hydroxymethyl 
 Figure 2. Relevant molecules involved in Maillard reaction. The ﬁ rst row includes  α -dicarbolyls, the second row collects cyclization products, 
and the third row shows carbonyl derivatives generated by sugar fragmentation. 
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  AGEs and ALEs: mechanisms of formation  7
furfural [57]. Notably, the chemical reactivity of these 
last  compounds decreases from left to right. 
 AGEs and their reactive precursors 
 AGE formation involves complex sequential and parallel 
reactions, whose precise mechanism is still debated 
even though at least two main pathways by which AGE 
can be generated are well established [58,59]. The ﬁ rst 
route involves irreversible rearrangements of the 
Amadori products following both oxidative and non-
oxidative pathways (see AGEs deriving from rearrange-
ment of the Amadori products). The second route involves 
condensation between the side-chain of lysine, cysteine 
and arginine residues, and dicarbonyls, which can 
be generated by enolization of Amadori products as well 
as by the direct degradation of aldoses and ketoses (as 
seen above). 
 Through multiple mechanisms, a large variety of AGE 
structures can be generated, some of which conserve 
completely the sugar carbon skeleton even though con-
densed to form aromatic rings, as in the case of crossline 
( 8.15 ), while other AGEs involve oxidative degradation 
with loss of sugar carbon atoms. The analysis of the 
valence of carbon atoms shows that oxidative reactions 
are not necessarily required in AGE formation and, in 
some cases, non-oxidative pathways can be involved 
depending also on the considered precursors. For this rea-
son, the term glycation is preferable to glycoxidation, 
which would not be broadly applied to all AGEs. 
 Although the following sections are clearly focused on 
endogenously formed AGEs, the dietary intake of food-
derived AGEs may signiﬁ cantly contribute to the total 
body AGEs load [60,61]. Several AGEs have so far been 
identiﬁ ed in heated foods, and indeed preclinical and 
clinical studies have demonstrated that an elevated intake 
of thermally processed foods might induce diabetogenic 
and nephrotoxic eﬀ ects, low-grade inﬂ ammation, enhance 
oxidative stress, and promote atherosclerosis [62,63]. 
Besides the AGEs which are also endogenously generated 
(e.g., carboxymethyllysine, pyrraline, pentosidine, see 
below) [64,65], some adducts are typically found only in 
heated foods since they derive by thermal degradation of 
AGEs. A well-known example is represented by  furosine 
(N6-(2-(2-Furanyl-2-oxoethyl))-L-lysine), which arises 
from the heating of fuctosyl lysine in weakly acid condi-
tions. Hence, furosine is a widely utilized marker to eval-
uate the nutritional quality of foods (especially for 
milk-based foods) by measuring the concentration of 
nutritionally available lysine residues [66]. 
 Finally, it is worth remembering that dicarbonyls and 
AGEs can react with speciﬁ c residues producing several 
nitrogen-, sulphur-, and oxygen-containing heterocyclic 
derivatives, which are potent aroma compounds. They 
include alkylpyrazines, oxazoles, oxazolines, tetrahydro-
pyridine, pyrroline, thiazoles, thiazolines, and pyrazino-
nes, which are generated at high temperature via Strecker 
degradation followed by decarboxylation and rearrange-
ment reactions [67]. 
 Glyoxal 
 Exogenous and endogenous sources. Glyoxal ( 2.1 ) is the 
smallest dialdehyde and appears as a yellow liquid, which 
forms hydrates in water solution. The hydrates tend spon-
taneously to condense to yield oligomeric species, the 
exact structures of which remain unclear [68]. Sources of 
glyoxal can involve both exogenous and endogenous path-
ways. The former include dietary and environmental 
sources, while the latter include various metabolic and 
oxidative reactions all of which are able to induce cellular 
damage [69]. 
 Speciﬁ cally, all foods, which are prepared by ferment-
ing, roasting, baking, or frying processes, are rich dietary 
sources of glyoxal [70]. Environmental sources include 
all products arising from combustion processes such as 
cigarette smoke, smoke from residential log ﬁ res, and 
vehicle exhaust, while detectable amounts of glyoxal are 
also found in soil, groundwater, seawater, and sediment 
[71]. Glyoxal coming from environmental sources can be 
absorbed through the gut, lungs, or skin even though the 
speciﬁ c role of each absorption route in aﬀ ecting glyoxal 
tissue levels is still debated. 
 With regard to endogenous production mechanisms, 
glyoxal can be essentially generated starting from sugars 
and lipids (plus their metabolites) [72]. Sugars can pro-
duce glyoxal through two major pathways. The ﬁ rst 
includes direct autoxidation reactions, which appear to be 
promoted by the presence of phosphates and transition 
metal ions, although the direct conversion of sugars in 
glyoxal can also involve retroaldol fragmentation [73,74]. 
The second pathway involves the Maillard reaction and 
occurs via Amadori products, which can be transformed 
into glyoxal by enolization as described above [75]. 
 Although sugars are often seen as the main source, 
glyoxal can also arise from lipid peroxidation. Indeed, the 
nonenzymatic peroxidation of polyunsaturated fatty acids, 
such as linoleic and linolenic acids, generates peroxide 
intermediates, which then degrade to yield a variety of 
oxidative products including glyoxal [76]. Lastly, ascor-
bate can also spontaneously hydrolyze into glyoxal 
through an unknown mechanism [77]. 
 Concerning the metabolic fate of glyoxal, the large 
majority is enzymatically converted in glycolate by GSH-
dependent glyoxalase system, which comprises two 
isozymes diﬀ ering for tissue and subcellular localization 
[78]. When GSH is depleted, as happens in many oxida-
tive-based disorders, other enzymes including aldehyde 
reductase, aldose reductase, carbonyl reductase, aldehyde 
dehydrogenase, and 2-oxoaldehyde dehydrogenase can 
contribute to the glyoxal metabolism [79]. Finally, several 
lines of evidence have revealed that glyoxal catabolism 
could be involved in oxalate formation as suggested, for 
example, by studies on diabetics showing that they have 
increased levels of both plasma glyoxal and urinary 
oxalate [80]. Such a pathway is catalyzed by glycolate 
oxidase and lactate dehydrogenase, involves glycolate as 
a key oxidized intermediate, and may inﬂ uence calcium 
oxalate stone formation [81]. 
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 Glyoxal-derived AGEs. The remarkable activity of 
glyoxal is clearly evidenced by the observation that 
more than 90% of glyoxal present in biological matrices 
is covalently bound to Cys, Lys, and Arg residues thus 
having a key role in protein glycation [82,83]. 
 As depicted by Figure 3, glyoxal can react with the 
lysine side chain to yield  N  e  -(carboxymethyl)lysine 
(CML,  3.1 ) through an aldimine intermediate, and with 
the cysteine thiol group to give an irreversible end 
product,  S-(carboxymethyl)cysteine (CMC,  3.2 ), the 
formation of which involves a Cannizzaro-like rear-
rangement of the corresponding thioacetal intermediate 
[84]. Notably, the single modiﬁ ed CMC amino acid has 
long been known as a mucolytic agent, and has attracted 
recent interest in the long-term treatment of chronic 
obstructive pulmonary disease (COPD) for its capacity 
to decrease the adhesion of bacteria to the upper respiratory 
tract [85]. 
 Figure 3 shows that the  in vivo reactions between the 
arginine side chain and glyoxal are clearly more complex 
[86], since they involve the formation of two possible 
dihydroxyimidazolidine intermediates:  G-DH1 ( 3.3 ), 
N  δ  - (3,4-dihydroxy-1-imidazolidin-2-yl) ornithine and 
its isomer  G-DH2 ( 3.4 ), (5-(4,5-dihydroxy-2-imino-1-
imidazolidinyl) norvaline. Both intermediates can (1) 
open to give the  N 7 -(carboxymethyl) arginine (CMA,  3.5 ) 
adduct [87] or (2) dehydrate to yield three diﬀ erent 
imidazolone derivatives, that is, N  δ  - (5-hydro-4-imidazolon-
2-yl) ornithine,  G-H1 ( 3.6 ), and its isomers 5-(2-amino-
5-hydro-4-imidazolon-1-yl) norvaline  G-H2 ( 3.7 ) and 
5-(2-amino-4-hydro-5-imidazolon-1-yl)norvaline,  G-H3 
( 3.8 ). Among the possible arginine adducts, the dihy-
droxyimidazolidines, despite acting as intermediates, are 
the most abundant followed by the imidazolones and 
CMA [88]. While considering that each protein residue 
possesses a speciﬁ c reactivity depending on its microen-
vironment, comparison of the possible adducts of lysine 
and arginine residues shows that the latter are usually 
more abundant thus emphasizing the greater susceptibil-
ity of arginine residues in producing AGEs [89]. Notably, 
all arginine-derived AGEs can degrade to give an orni-
thine residue, which can in turn react with glyoxal gen-
erating a set of ornithine-based AGEs, similar to those 
observed for lysine as exempliﬁ ed by the formation of 
 carboxymethylornithine (CMO) [90]. 
 Due to its dicarbonyl structure, glyoxal can also react 
with two lysine or arginine residues yielding imidazol 
cross-linked adducts. As represented in Figure 3, 
glyoxal can react with two lysine residues giving the 
corresponding glyoxal – lysine dimer ( GOLD ,  3.9 , 6-
{1-[(5S)-5-ammonio-6-oxido-6-oxohexyl]imidazolium-
3-yl}-L-norleucine) whose mechanism of formation is 
common to the corresponding methylglyoxal containing 
dimer (see below) and involves an initial bis lysyl diimine 
intermediate, which reacts with a second glyoxal 
molecule through a Cannizzaro-type reaction, and, after 
dehydration, condenses to give the ﬁ nal imidazolium 
dimer [91]. 
 Figure 3. Major pathways for the formation of the glyoxal-derived AGEs  in vivo. 
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  AGEs and ALEs: mechanisms of formation  9
 The cross-linking reaction between arginine, lysine, 
and glyoxal gives the  GODIC product ( 3.10 , N6-(2-
{[(4S)-4-ammonio-5-oxido-5-oxopentyl]amino}-3,5-
dihydro-4H-imidazol-4-ylidene)-L-lysine) which involves 
the initial formation of an imine intermediate coming 
from lysine plus glyoxal and then reacts with the argin-
ine ’ s guanidine group to yield, after dehydration, the ﬁ nal 
4,5-dihydro-1H-imidazol derivative [92]. Lastly, two 
lysine residues can react with glyoxal via Strecker 
deg radation to yield the amide adduct,  GOLA ( 3.11 , 
N6-(2-{[(5S)-5-ammonio-6-oxido-6-oxohexyl] amino}-
2-oxoethyl)-L-lysine) which can be derived also through 
oxidative fragmentation of the Amadori products and 
which appears to be favored with increased glyoxal con-
centrations [93,94]. 
 Methylglyoxal 
 Exogenous and endogenous sources. Methylglyoxal ( 2.2 ), 
also called pyruvaldehyde or 2-oxopropanal (CH 3 – CO –
 CHO or C 3 H 4 O 2 ), is a yellow liquid with a characteristic 
pungent odor. It is ubiquitous in living cells and therefore 
almost all foods contain methylglyoxal, the concentration 
of which is increased by processes such as cooking [95], 
fermentation, and prolonged storage [96]. In foods and 
beverages, the main sources of methylglyoxal are repre-
sented by sugars and lipids [70]. Sugars can generate 
methylglyoxal through retro-aldol reaction or auto-oxida-
tive fragmentation and, although these processes are 
greatly favored by alkaline conditions, they can also occur 
during caramelization by the heating of mono-, oligo-, 
and polysaccharides [97,98]. Besides heating processes, 
also prolonged storage can degrade sugars to generate 
methylglyoxal through a process which is especially 
favored in foods with a high content of simple carbohy-
drates [99]. Due to industrial manufacturing and storage, 
also lipids can fragment inducing accumulation of meth-
ylglyoxal [100]. Thus, heating and photodegradation are 
two well-known processes with which lipids can yield 
methylglyoxal as a degradation product. Lastly, many 
microorganisms produce and release methylglyoxal and 
thus fermentation can cause an increase of this dicarbonyl 
product in alcoholic drinks and fermented foods [101]. 
Regarding environmental sources and similarly to what 
has already been seen with glyoxal, combustion processes 
can generate methylglyoxal, as in the case of cigarette 
smoke, which indeed is one of the major sources of air 
contamination by this toxic dicarbonyl compound [102]). 
Drinking water can contain methylglyoxal commonly 
because of the applied puriﬁ cation processes [103], while 
rainwater can absorb methylglyoxal from polluted air and 
conveys it to the soil [71]. 
 Endogenous sources of methylglyoxal involve many 
pathways that can be subdivided into enzymatic or nonen-
zymatic reactions [104 – 107]. As represented by Figure 4, 
the former includes reactions catalyzed by methylglyoxal 
synthase, cytochrome P450 2E1, myeloperoxidase, 
and amino oxidase, whereas the latter include the spon-
taneous decomposition of dihydroxyacetone-phosphate, 
the Maillard reaction, the oxidation of acetol, and lipid 
peroxidation [106]. In more detail, the main route leading 
to methylglyoxal involves the enzymatic or nonenzymatic 
degradation of the triose phosphate intermediates origi-
nating from the glycolytic processes [105]. The intermedi-
ates include glyceraldehyde 3-phosphate ( 4.4 ) and 
dihydroxyacetone-phosphate ( 4.5 ), which are in equilib-
rium due to the activity of triosephosphate isomerase 
[108,109]. Thus, dihydroxyacetone-phosphate can yield 
methylglyoxal by both spontaneous nonenzymatic elimi-
nation of the phosphate group and by the eﬀ ect of meth-
ylglyoxal synthase, an enzyme found in procaryotic and 
mammalian systems and inhibited by inorganic phosphate 
ions [101,110]. Similarly to what was observed during 
food cooking, methylglyoxal can also derive via the 
 Maillard reaction  in vivo under physiological conditions. 
 Lipids can take part in the methylglyoxal generation 
through the acetone metabolism [111]. In detail, acetone 
( 4.7 ) derives from acetoacetate ( 4.6 ) by myeloperoxidase 
activity and is converted to methylglyoxal by the cyto-
chrome P450 2E1 via acetol ( 2.14 ) as intermediate [112]. 
Particular pathophysiological conditions, such as ketosis 
and diabetic ketoacidosis, signiﬁ cantly increase methylg-
lyoxal generation from acetone [113]. Yet again, glycerol 
( 4.8 ) resulting from triacylglycerol hydrolysis can be 
transformed into methylglyoxal through the glycerolphos-
phate ( 4.9 ) intermediate which is produced by a speciﬁ c 
glycerol kinase [114]. Threonine and glycine can also 
generate methylglyoxal through the aminoacetone inter-
mediate ( 4.10 ) [115]. This metabolic pathway is mediated 
by semicarbazide sensitive amine oxidase (SSAO) and 
appears to be exacerbated in low coenzyme A states 
[116,117]. 
 Diﬀ erent enzymes contribute to methylglyoxal detoxi-
ﬁ cation among which the glyoxalase system, aldose 
reductase (ALR), betaine aldehyde dehydrogenase, and 
2-oxoaldehyde dehydrogenase play a key role [118 – 
120]. The above-described glyoxalase system catalyzes 
the biotransformation of methylglyoxal to D-lactate 
( 4.11 ), which in turn is converted into pyruvate ( 4.12 ) by 
D-lactate dehydrogenase. Aldose reductase (ALR2, 
AKR1B1) catalyzes the NADPH-dependent reduction of 
methylglyoxal into lactaldehyde ( 4.13 ) or into acetol 
when GSH is depleted [121]. ALR then transforms both 
products into 1,2-propandiol ( 4.14 ) even though this ﬁ nal 
reaction is markedly more favored for lactaldehyde com-
pared to acetol which consequently tends to accumulate 
in the absence of GSH. Since acetol spontaneously con-
verts into methylglyoxal, the reduction of methylglyoxal 
in the absence of GSH could result in a vicious circle with 
nil eﬀ ect [122]. Nonspeciﬁ c aldehyde dehydrogenases 
can recognize substrates only in their anhydrate forms 
and thus they cannot detoxify methylglyoxal and other 
 α -oxoaldehydes, which are completely hydrated under 
physiological conditions [123]. However, methylglyoxal 
is substrate for betaine aldehyde dehydrogenase (ALDH9 
or E3) which indeed contributes to its detoxiﬁ cation 
[124]. Moreover, the missing activity of nonspeciﬁ c alde-
hyde dehydrogenases is counterbalanced by the speciﬁ c 
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10 G. Vistoli et al. 
2-oxoaldehyde dehydrogenase (2-ODH) which catalyzes 
the NAD/NADPH-dependent oxidation of methylglyoxal 
into pyruvate ( 4.12 ). The enzyme also requires an activa-
tor: vicinal aminoalcohols, aminothioles, and glycine 
were found to act as activators even though the physio-
logical activator is still unknown [125]. 
 Methylglyoxal-derived AGEs. It has long been known that 
methylglyoxal is able to induce irreversible modiﬁ cations 
in proteins under physiological conditions [126 – 128]. 
The formed adducts can be grouped into ﬂ uorescent and 
nonﬂ uorescent products. Speciﬁ cally and as schematized 
by Figure 5, methylglyoxal reacts primarily with arginine 
residues yielding cyclic imidazolone adducts [129], 
whose formation mechanism involves ﬁ rstly the conden-
sation between a carbonyl group and the N 7 guanidino 
atom to give the corresponding carbinolamine which then 
cyclizes to form the diol intermediates and to yield the 
ﬁ nal adducts through two successive dehydrations [130]. 
From a kinetic point of view, cyclization is a fast reaction 
while the two eliminations represent the slow and rate-
determining steps [131]. Depending on the nitrogen atoms 
involved in the cyclization and on environmental pH 
value, three diﬀ erent adducts are possible, as represented 
in Figure 5, namely N  δ  -(5-methyl-4-imidazolon-2-yl)-L-
ornithine ( MG-H1 ,  5.1 ), 2-amino-5-(2-amino-5-hydro-5-
methyl-4-imidazolon-1-yl)pentanoic acid ( MG-H2 ,  5.2 ), 
2-amino-5-(2-amino-4-hydro-4-methyl-5-imidazolon-1
-yl)pentanoic acid ( MG-H3 ,  5.3 ). These three imidazolone 
adducts are in equilibrium since they can open giving 
the  carboxyethylarginine (CEA, 5.4) adduct which in turn 
re-cyclizes allowing mutual interconversion between the 
imidazolone adducts [132]. 
 Besides the mentioned ring opening, the imidazolone 
adducts can undergo other reactions as depicted by Figure 
5. In more detail, they can add a second methylglyoxal 
molecule yielding either  THP ( 5.5 , N  δ  -(4-carboxy-4,6-
dimethyl-5,6-dihydroxy-1,4,5,6-tetrahydropyrimidine-2-
yl)-L-ornithine) through an open intermediate [133] and 
a ﬁ nal re-cyclization reaction or  argpyrimidine , ( 5.6 , N  δ  -
(5-hydroxy-4,6-dimethylpyrimidine-2-yl)-l-ornithine), a 
ﬂ uorescent derivative via decarboxylation and dehydra-
tion [134]. Although THP would theoretically give arg-
pyrimidine through a reaction triggered by the gained 
aromaticity, no experimental evidence has hitherto been 
found to support such a pathway. 
 Methylglyoxal can react with lysine residues generat-
ing the  carboxylethyllysine (CEL,  5.7 ) adduct through a 
mechanism, which involves an aldimine intermediate and 
brings to mind the already mentioned pathway for the 
formation of the nor-analogue carboxymethyl lysine ( 3.1 ) 
[135]. Notably, the aldimine intermediates can oxidize 
through a metal-catalyzed process giving deaminated 
allysine (adipic semialdehyde). This latter further oxi-
dizes to yield 2-amino adipic acid, which indeed accumu-
lates in oxidative-based disorders [136]. 
 Figure 4. Schematized pathways for MGO formation and catabolism (dotted lines indicate nonenzymatic MGO formation). Adapted 
from [105]. 
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  AGEs and ALEs: mechanisms of formation  11
 As already seen for glyoxal, the aldimmine intermedi-
ate can react with the arginine guanidine group yielding 
a cyclic intermediate that, after dehydration and rear-
rangement, produces the ﬁ nal cross-link imidazol  MODIC 
adduct ( 5.8 , 2-ammonio-6-({2 – [4-ammonio-5-oxido-5-
oxopently)amino]-4-methyl-4,5-dihydro-1H-imidazol-5-
ylidene}amino)hexanoate) with an overall mechanism 
almost identical to that described for GODIC ( 3.10 ) for-
mation, even though this latter appears to be favored as 
suggested by experimental and computational results 
[91,92]. 
 Yet again, similarly to what was described for glyoxal, 
methylglyoxal can react with two lysine residues forming 
an initial diimine intermediate, which then adds a second 
methylglyoxal molecule and, via an intermolecular Can-
nizzaro-type reaction, yields the ﬁ nal imidazolium  MOLD 
adduct ( 5.9, 6-{1-[(5S)-5-ammonio-6-oxido-6-oxohexyl]-
4-methyl- imidazolium-3-yl}-L-norleucine) [137]. This 
cross-link reaction occurs more eﬃ  ciently with methylg-
lyoxal compared to glyoxal and this diﬀ erence is in agree-
ment with the proposed mechanism since the required 
fragmentation reaction is more favorable for methylgly-
oxal, due to increased relative stability of the leaving 
group [138]. Lastly, methylglyoxal can react with cysteine 
residues giving reversible hemithioacetal adducts ( 5.10 ) 
[130] and with tryptophan residues yielding  β carboline 
derivatives, a particularly common reaction during pro-
longed food storage [96,139]. 
 3-Deoxyglucosone 
 Exogenous and endogenous sources 
 3-Deoxyglucosone [3-DG, (4S,5R)-4,5,6-trihydroxy-2-
oxohexanal] is a highly reactive dicarbonyl compound 
that, as schematized in Figure 6, mostly arises from the 
rearrangement of the Amadori products [140]. These lat-
ter are formed via Maillard reaction and then undergo 
enolyasation and deydratation reactions to generate dicar-
bonyl species, among which 3-Deoxyglucosone (3-DG) 
is one of the most reactive products in condensing with 
free amino groups in proteins to form AGEs during the 
late stage of the Maillard reaction [141,142]. The forma-
tion of 3-DG via Amadori products was found to be 
increased in nonaerobic conditions and in the presence of 
phosphate ions. 
 With regard to 3-DG dietary sources, all foods, which 
are particularly rich in sugar content and the preparation 
of which involves cooking, ripening, and fermentation, 
are signiﬁ cant dietary sources of 3-DG (e.g. [143]). In 
more detail, 3-DG is found at signiﬁ cant concentrations 
in all alcoholic and nonalcoholic drinks whose sugar 
content is due to the presence of monosaccharides, like 
glucose and fructose, artiﬁ cially added as syrup or deriv-
ing from the raw material [144]. Conversely, sucrose-
containing beverages show markedly lower 3-DG 
concentrations because of the greater stability of 
the disaccharide ’ s acetal structure. Vinegars, especially 
 Figure 5. Major pathways for the formation of the methylglyoxal-derived AGEs  in vivo. 
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balsamic vinegars, and soy sauces show very high 3-DG 
levels, a result which is easily explainable considering 
their manufacturing processes, which involve, as in the 
case of balsamic vinegars, prolonged heating and fermen-
tation of must. Since dicarbonyls are well-known precur-
sors of aroma ingredients, the stated 3-DG content should 
play a crucial role in the aromatizing capabilities of these 
condiments [145]. The reported data should be seen as 
examples showing the vast presence of 3-DG in foodstuﬀ s 
and the interested reader can refer to specialized reviews 
to analyze the 3-DG content in common foods [70]. 
 Beside the already discussed Maillard reaction, the 
endogenous pathways leading to the 3-DG formation 
include the polyol pathway [146]. In detail, 3-DG is non-
enzymatically generated in the absence of amino groups 
by the oxidation of fructose ( 6.2 ) [147]. This latter, as 
described in Figure 6, can also arise from glucose ( 1.1 ) 
via sorbitol ( 6.1 ) as intermediate due to the enzymatic 
activity of ALR and sorbitol dehydrogenase, a metabolic 
route particularly active in diabetes [148]. Again, 3-DG 
can derive from the hydrolysis of fructose-3-phosphate 
( 6.3 ) which is enzymatically generated starting from 
fructose by fructosamine 3-kinase [149], and was found 
to be accumulated in diabetic animal models [150]. 
 The formed 3-DG can permeate the cellular membrane 
and thus is taken up by cells, where it is reduced to 
3-deoxy fructose ( 6.4 ) by ALR as conﬁ rmed by the obser-
vation that aldose reductase inhibitors (ARI) exacerbate 
the 3-DG induced protein glycation [151]. Moreover, 
3-DG can be enzymatically oxidized into a nonreactive 
2-keto-3-deoxygluconic acid ( 6.5 ) by the eﬀ ect of 
aldehyde dehydrogenase 1A1 (ALDH1A1), which is a 
NAD-dependent dehydrogenase that acts at neutral pH 
and is known to catalyze the oxidation of retinaldehyde 
to retinoic acid [152]. Unfortunately, a fraction of 3-DG 
can nonenzymatically oxidize into very reactive and toxic 
3,4-dideoxyglucosone-3-ene (3,4-DGE,  6.6 ) which 
combines the dicarbonyl reactivity with that of  α , β 
unsaturated carbonyls and which is generated under very 
oxidative pathophysiological conditions such as those 
observed during peritoneal dialysis [153,154]. This 
very reactive compound can also hydrate giving 
3-deoxygalactosone (3-DGal,  6.7 ) which is thus in equi-
librium with 3DG through the 3,4-DGE derivative as 
common intermediate [155]. 
 Deoxygluocosone-derived AGEs 
 Several studies evidenced that 3-DG quickly reacts with 
residues in proteins forming a variety of AGE structures 
among which imidazolones and carboxymethyl lysine 
appear to be the most abundant ones [156]. As schema-
tized in Figure 7, 3-DG can easily attack arginine residues 
forming dihydroimidazole derivatives, which dehydrate 
to yield the ﬁ nal imidazolone adducts [157,158]. As seen 
for glyoxal and methylglyoxal, also 3-DG can generate 
three distinct imidazolone adducts, namely,  3DG-H1 , 
( 7.2 , N  δ  -[5-hydro-5-(2,3,4-trihydroxybutyl)-4-imidazo-
lon-2-yl] ornithine,  3DG-H2 (5-[2-amino-5-hydro-5-
(2,3,4-trihydroxybutyl)-4-imidazolon-1-yl] norvaline), 
 Figure 6. Schematized pathways for 3-DG formation and catabolism. 
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  AGEs and ALEs: mechanisms of formation  13
and  3DG-H3 , (5-[2-amino-4-hydro-4-(2,3,4-trihydroxy
butyl)-5-imidazolon-1-yl] norvaline), although in Figure 
7 only 3DG-H1 is displayed for the sake of simplicity. In 
fact and under physiological conditions, the reaction 
between 3-DG and arginine leads to the accumulation of 
the initial dihydroimidazole adducts, while the formation 
of the ﬁ nal imidazolones is slow and appears to be favored 
only at high temperatures. Nevertheless, several lines of 
evidence reveal that imidazolone adducts are a common 
marker of 3-DG-modiﬁ ed proteins and are present  in vivo 
at high concentrations in diabetic animal models [159]. 
 3-Deoxyglucosone, and more generally all 3-deoxyo-
sones [160], can react with a lysine residue forming, 
through a Paal – Knorr reaction, a pyrrole containing 
adduct called  pyrraline ( 7.3 ) or pyrrole lysine, 6-(2-form-
yl-5-hydroxymethyl-1-pyrrolyl)-L-norleucine [161,162]. 
A similar cyclization product,  formyline ( 7.4 ), has recently 
been identiﬁ ed from the reaction between lysine and 
3-deoxypentosone ( 7.1 ). Formyline, or (6-(2-formyl-1-
pyrrolyl)-L-norleucine, is generated by the dehydratation 
of 3-deoxypentosone to yield 3,4-dideoxypentosone-3-
ene ( 7.5 ) which then reacts with lysine to generate this 
cyclic adduct [163]. Pyrrole containing adducts can also 
arise from the lipid peroxidation reactions of 4,5-epoxy-2-
alkenals which are degradation products of the  ω -3 and 
 ω -6 fatty acids [164].  In vivo and under oxidative condi-
tions, pyrraline can induce protein cross-linking by gen-
erating ether bonds with cysteinyl thiol function or other 
pyrraline adducts [165]. Interestingly, pyrraline contain-
ing dipeptides are recognized and transported at intestinal 
level by hPepT1, a di/tripeptide transporter, which 
therefore would be responsible for the intestinal absorp-
tion of pyrraline dipeptides after food intake [166]. How-
ever and as mentioned above, the major adduct between 
3-DG and lysine residues is represented by carboxym-
ethyl lysine (CML,  3.1 ) which derives from degradation 
of the initial 3DG-Lys adduct thus indicating that the 
3-DG can signiﬁ cantly contribute along with glyoxal to 
the CML adducted proteins as observed in  in vivo studies 
[146,167]. 
 Regarding the cross-linking adducts, 3-Deoxyglucosone 
can react with two lysine residues yielding a 3-deoxy
glucosone lysine dimer,  DOLD ( 7.6 , 1,3-di(N  ε  -lysino)
-4-(2,3,4-trihydroxybutyl)-imidazolium), a cross-link 
resulting from the reaction between hippuryl-lysine and 
3-deoxyglucosone as characterized by Skovsted et  al. 
[135,168]. As depicted in Figure 7, 3-DG can cross-link 
arginine and lysine residues forming an imidazol adduct 
N 6 -{2-{[(4S)-4-ammonio-5-oxido-5-oxopentyl]amino}-5
-[(2S,3R)-2,3,4-trihydroxybutyl]-3,5-dihydro-4H-imida-
zol-4-ylidene}-L-lysinate, which exists as a mixture of 
two diastereoisomers and has been named  DOGDIC ( 7.7 , 
aka  DODIC ) in accordance with the acronyms GODIC 
and MODIC already seen for the corresponding glyoxal 
and methylglyoxal adducts [169]. A similar adduct is 
also formed by 3-deoxypentosone which produces the 
corresponding  DOPDIC product ( 7.8 , N 6 -{2-{[(4S)-4-
ammonio-5-oxido-5-oxopentyl] amino}- 5-[(2S)-2,3-
dihydroxypropyl]-3,5-dihydro-4H-imidazol-4-ylidene}-
L-lysinate [170]. Reihl et  al. evidenced that DOGDIC, 
 Figure 7. Major pathways for the formation of the 3-DG-derived AGEs  in vivo . 
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DOPDIC, and more generally all imidazolone adducts 
can further oxidize under physiological conditions to give 
the corresponding spiro [4,4] amino imidazol analogues 
(e.g.  DOGDIC-Ox ,  7.9 ) [171]. Comparative analyses 
showed that imidazolones and CML are produced in 
similar high concentrations in the presence of 3-DG, 
while pyrraline and DOGDIC are generated in a markedly 
lower amount and accumulate only at high (nonphysio-
logical) temperatures [156]. Lastly, 3-DG can react 
with two lysine residues forming the cross-linking 
 lysyl-pyrropyridine adduct ( 7.10 ), the level of which is 
increased in diabetic rats thus suggesting that its forma-
tion might be related to the progression of diabetic com-
plications [45]. 
 AGEs deriving from rearrangement of the Amadori 
products 
 As described before and due to the instability of its acetal 
form, fructose ( 6.2 ) is particularly reactive in condensing 
with protein amino groups to give the corresponding 
Amadori products. In detail, Figure 8 shows that fructose 
can condense with the free N-terminus or more 
frequently with the lysine side chain to yield the N- ε -
fructosyl lysine adduct ( 8.1 ) [172]. Despite being less 
reactive, glucose can also condense with lysine residues 
giving the corresponding N- ε -glucosyl lysine adduct 
( 8.2 ) [173]. Under physiological conditions, these 
Amadori products can oxidize and rearrange to give 
the corresponding reactive dideoxyosones (namely,  8.3 , 
N 6 -(2-hydroxy-4,5-dioxopentyl)-L-lysine for N- ε -fructosyl 
lysine and N 6 -(2,3-dihydroxy-5,6-dioxohexyl)-L-lysine 
for N- ε -glucosyl lysine,  8.4 ) [174]. 
 At physiological pH, N- ε -fructosyl lysine can further 
oxidize to form carboxymethyl lysine (CML,  3.1 ) and 
erythronic acid ( 8.5 ), while in slightly more acid 
conditions it yields N- ε -lysine lactic acid ( 8.6 ) plus glyc-
eric acid ( 8.7 ), thus suggesting that the chemical fate of 
N- ε -fructosyl lysine strongly depends on the environmental 
pH [175]. 
 As schematized in Figure 8, N- ε -glucosyl lysine can 
react with arginine side chains forming a bicyclic non-
ﬂ uorescent cross-linking adduct,  glucosepane ( 8.8 , 
2-acetylamino-5-[(4-butyl-6,7-dihydroxy-4,5,6,7,8,8a-
hexahydroimidazo[4,5-b]azepin-2-yl)amino]-pentanoic 
acid) [176], whose mechanism of formation is still 
debated. Its ﬁ rst step involves the conversion of the Ama-
dori product into dideoxyosone ( 8.4 ) via dehydration and 
rearrangement reactions. Afterward, dideoxyosone ﬁ rstly 
cyclizes to form an azepinone intermediate (i.e. 6-(3,4-
dihydroxy-6-oxo-3,4,5,6-tetrahydro-2H-azepinium-1-yl) 
nor-leucine) which then condenses with the arginine ’ s 
guanidino group to generate the ﬁ nal glucosepane adduct. 
An alternative route should also be possible in which the 
Amadori product ﬁ rstly condenses with the arginine side 
chain to yield an imidazol intermediate, which then 
cyclizes and forms the glucosepane product [177]. 
Glucosepane can exist in four diastereoisomeric pairs, 
whose relative abundance strongly depends on the protein 
environment in which they are formed [174]. Whatever 
 Figure 8. Major pathways for the formation  in vivo of the AGEs deriving from direct rearrangement of the Amadori products. 
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the mechanism of formation is, glucosepane is the most 
abundant cross-linking AGE found in senescent extracel-
lular matrix accounting for the structural and cellular 
dysfunctions observed in aging and diabetes [170,178]. 
As already seen for other AGEs, also glucosepane can be 
transformed into ornithine thus conﬁ rming that all argin-
ine-containing AGEs can be seen as  in vivo nonenzymatic 
sources of ornithine [179]. 
 As shown in Figure 8, pentose-derived Amadori prod-
ucts can undergo a quite similar reaction scheme giving 
the ﬂ uorescent adduct  pentosidine ( 8.9, 6-[2-[[(4S)-4-
amino-5-hydroxy-5-oxopentyl] amino]-4-imidazo [4,5-b]
pyridinyl]-L-norleucine) [180 – 182] the formation of 
which involves a nonaromatic intermediate  pentosinane , 
( 8.10 , 6-((6S)-2-{[(4S)-4- ammonio-5- oxido-5- oxopen-
tyl] amino}-6-hydroxy-5,6,7,7 a-tetra hydro -4H imidazo 
[4,5-b]pyridin-4-yl)-L-norleucine), which then dehy-
drates and aromatizes to give the ﬁ nal pentosidine [183]. 
Under oxidative conditions, pentosidine can also result 
from reactions of lysine and arginine residues with hexo-
ses, ascorbate, 3-deoxyglucosone (3-DG), glyceralde-
hydes and glycolaldehyde [184]. Recent experimental and 
computational studies have demonstrated that pentosidine 
can also be generated by the reaction of lysine and argi-
nine residues with two molecules of short-chain  α -oxoal-
dehydes, such as glyoxal (GO) and methyl glyoxal (MGO), 
as observed in uremic patients [185]. The reaction between 
lysine-containing Amadori products and arginine can 
ﬁ nally generate two already-described imidazole adducts, 
namely DOGDIC ( 7.7 ) from hexoses and DOPDIC ( 7.8 ) 
from pentose sugars [170,178]. 
 Glucose-derived, lysine-containing Amadori products 
can react with a second lysine residue forming three pos-
sible ﬂ uorescent cross-linking pyrrolopyridinium adducts, 
named  vesperlysines A ( 8.11 ), B ( 8.12 ), and C ( 8.13 ) 
[186]. The original six carbon atoms of glucose are not 
completely incorporated into vesperlysines thus suggest-
ing that they are glyco-oxidation adducts derived from 
two glucose molecules through dehydration, oxidative 
fragmentation, and condensation of the sugar moieties. 
Moreover, they can be formed from shorter chain sugars, 
for example, ribose and glyceraldehyde [187]. 
 Glucose-derived lysine-containing Amadori products 
can also react with each other giving dimer cross-link 
adducts which can form directly or via the 1,4-dideoxy-
5,6-dioxoglucosone intermediate. In the ﬁ rst case, they 
form a recently identiﬁ ed imidazolium adduct named 
 GLUCOLD ( 8.14 , 1,3-bis-(5-amino-5-carboxypentyl)-4-
(1,2,3,4-tetrahydroxybutyl)-3H-imidazolium) [188]. In 
the second case, the cited intermediate cyclizes to give a 
tetrahydropyridinium ring which adds a second Amadori 
product and after dehydration and rearrangements yields 
the ﬁ nal  crossline adduct ( 8.15 ) [189]. Regardless of the 
protein content of lysine and arginine residues, dimer 
cross-links are found in negligible amounts compared to 
glucosepane (21, 1 and 611 pmol/mg, for GLUCOLD, 
crossline and glucosepane, respectively). Mechanistic 
studies have revealed that the rapid formation of the N 6 -
1,4-dideoxy-5,6-dioxoglucosone intermediates and their 
facile reaction with the guanidino group can easily explain 
the vast majority of arginine-containing adducts [188]. 
 ALEs: an introduction 
 The term ALEs (advanced lipoxidation end products) 
includes a variety of adducts and cross-links which are 
generated by the nonenzymatic reaction of RCS produced 
by lipid peroxidation and the lipid metabolism with the 
nucleophilic sites of macromolecules such as proteins, 
DNA, and aminophospholipids, leading to their irrevers-
ible modiﬁ cation [190] . The most-studied ALEs are those 
arising from the reaction of RCS break-down products of 
the lipid peroxidation cascade with the nucleophilic resi-
dues of proteins, mainly Cys, Lys, His, and Arg residues. 
As schematized in Figure 9, the RCS arising from the 
lipid peroxidation cascade are quite heterogeneous and 
can be divided into three main classes, namely : (1) the 
 α , β -unsaturated aldehydes, including hydroxylated, such 
as 4-hydroxy-2-nonenal (HNE,  9.1 ) and 4-hydroxy hex-
enal (HHE,  9.2 ), and nonhydroxylated derivatives, non-
enal ( 9.3 ) and acrolein (ACR,  9.4 ); (2) di-aldehyde, 
including the well-known lipid peroxidation by product 
malondialdehyde ( 9.5 ) and glyoxal ( 2.1 ); 3) cheto-alde-
hyde such as methylglyoxal ( 2.2 ), 4-oxo-nonenal (ONE, 
 9.6 ), and the isoketals also called levuglandins (LGs, as 
exempliﬁ ed in Figure 8 by LGD 2 ,  9.7 ) which are gamma-
ketoaldehydes formed via the isoprostane pathway of 
arachidonic acid peroxidation. 
 The RCS acting as precursor of ALEs, besides includ-
ing the short-chain carbonyl derivatives generated by 
the break-down of nonenzymatic lipoxidation-derived 
hydroperoxides, also include the oxidized truncated phos-
pholipids, where the electrophilic moiety remains cova-
lently linked to the phospholipid [191]. Figure 8 shows 
some exempliﬁ cative phospholipid-based RCS, including 
 γ -hydroxy- α , β -unsaturated aldehyde phospholipid ( 9.8 ), 
 γ -keto- α , β -unsaturated aldehyde phospholipid ( 9.9 ), and 
 γ -keto- α , β -unsaturated carboxylic phospholipid ( 9.11 ) 
[192]. As in the case of short-chain RCS, also the oxi-
dized phospholipids containing electrophilic moieties are 
able to covalently react with the nucleophilic sites of pro-
teins forming Michael adducts or Schiﬀ  bases. Although 
the ALEs formed by short-chain RCS have been much 
more studied in respect to those generated by oxidized 
phospholipid, some protein and peptide targets of oxi-
dized phospholipid have already been identiﬁ ed, such as 
cathepsin B [193] and angiotensin II [194]. 
 It should be noted that although the chemical reactions 
of RCS in free form or bound to phospholipid are practi-
cally the same and mainly based on the formation of 
Michael adduct or Schiﬀ  base as below described, the 
protein targets might be diﬀ erent since the two classes of 
compounds have a quite diﬀ erent lipophilicity and con-
sequently a diﬀ erent cellular distribution. 
 The above-mentioned RCS are generated by a common 
lipid-peroxidation cascade, which can involve free 
polyunsatured fatty acids (PUFAs) or phospholipids. An 
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additional class of RCS able to form protein adducts is 
represented by electrophilic prostaglandin metabolites, 
which are characterized by an  α , β -unsaturated carbonyl 
moiety (cyclopentenone). Among these RCS, it is worth 
mentioning PGA2 ( 9.12 ) generated from the dehydration 
of PGE2 and 15-deoxy- Δ 12,14 -prostaglandin J2 (15d-PGJ2, 
 9.14 ) which is generated as a consequence of dehydration 
of PGD2, a principal COX-2 product formed in various 
cells and tissues during the inﬂ ammatory processes 
[195,196]. 
 It should be stressed that some RCS such as glyoxal 
and methylglyoxal are generated by the oxidative path-
ways involving both lipids and sugars, thus the corre-
sponding reaction products with proteins can be named 
both as ALEs and AGEs or as EAGLEs (either advanced 
glycation or lipoxidation endproducts). 
 α , β -unsaturated carbonyls 
 Exogenous and endogenous sources 
 Regarding the endogenous sources of  α , β -unsaturated 
carbonyls, lipid peroxidation represents the major mecha-
nism by which they can be generated  in vivo [197,198]. 
Lipid peroxidation is initiated by the generation of free 
radicals close to cellular membranes, which represent rich 
sources of PUFAs. Hence, the levels of  α , β -unsaturated 
carbonyls is strictly related to radical formation and 
 consequently to oxidative stress conditions. It should be 
noted that moderate concentrations of free radicals are 
generated also under physiological conditions because of 
oxidase activity, imperfection in mitochondrial electron 
transport, and/or as a part of diﬀ erent metabolic pro-
cesses. However, cells maintain redox homeostasis 
through scavenging enzyme cascades (i.e., superoxide 
dismutase, catalase, and glutathione peroxidase) as well 
as protective factors (i.e., GSH, vitamin C, and vitamin 
E) [199]. Pro-oxidant conditions can dysregulate oxida-
tive enzymes inducing an overproduction of free radicals 
which are no longer counteracted by redox homeostasis 
thus resulting in cellular damage caused by both free 
radical species and the so generated nonradical oxidants. 
In detail, radical species (mainly, HO • and ONOO    ) 
attack PUFA molecules by abstracting an allylic hydrogen 
atom [200]. This generates a less-reactive carbon-
centered lipid radical (L • ) which in turn reacts with 
molecular oxygen to yield lipid peroxyl (LOO • ) and lipid 
alkoxyl radicals (LO • ), both of which can generate reac-
tive  α , β -unsaturated aldehydes [201]. 
 With regard to ACR ( 9.4 ) endogenous generation, it 
also involves the myeloperoxidase-mediated degradation 
of threonine as well as the amine oxidase-mediated deg-
radation of spermine and spermidine, reactions which are 
particularly relevant in situations of oxidative stress and 
inﬂ ammation [202,203]. 
 The  α , β -unsaturated carbonyls are readily detoxiﬁ ed 
by glutathione via a Micheal addition which can occur 
 Figure 9. Structures of the most reactive carbonyl species arising from lipidoxidation break-down and prostaglandin metabolism. 
D
ow
nl
oa
de
d 
by
 [I
ns
tit
ut 
Ru
de
r B
os
ko
vic
] a
t 0
5:0
0 2
5 A
ug
us
t 2
01
7 
  AGEs and ALEs: mechanisms of formation  17
spontaneously but is one hundred times faster when 
 catalyzed by glutathione-S-transferases (GSTs) [204]. 
Other metabolic reactions can involve the carbonyl func-
tion that can be either reduced into alcohol or oxidized 
into acid, involving alcohol dehydrogenase or aldo/keto 
reductases (AKR) and aldehyde dehydrogenase, respec-
tively [205]. Notably, these redox reactions can also 
involve GSH conjugates and indeed the reduced mercap-
turic acid of HNE, namely 1,4-dihydroxy nonane mercap-
turic acid (DHN-MA), is the major metabolite found in 
urine [206]. 
 While HNE ( 9.1 ) is almost exclusively formed endog-
enously, ACR ( 9.4 ) is ubiquitously present in foods and 
in the environment, which might help understanding of 
the mostly cytotoxic eﬀ ects of ACR on the one hand and 
cytotoxic and regulatory eﬀ ects of HNE on the other 
[207,208]. 
 It is generated by heat-induced dehydration and decom-
position reactions of sugars, lipids, and amino acids dur-
ing food cooking [209]. Environmental sources include 
combustion of petroleum fuels and biodiesel [210] and 
industrial manufacturing since ACR is an important inter-
mediate for the production of acrylic acid and plastics 
[211]. Nonetheless, smoking of tobacco products repre-
sents the major source of the total human exposure to 
ACR [212,213] as demonstrated by the level of its main 
metabolite, namely 3-hydroxypropyl mercapturic acid, in 
urine of smokers, which is about twice than that of non-
smokers [214]. 
 ALEs formed by  α , β -unsaturated carbonyls 
 Most of the lipid-derived RCS are characterized by a 
carbonyl group (a keto or an aldehyde function) which 
is conjugated to a double bond and which regulates the 
electrophilic reactivity toward the nucleophilic moieties. 
In particular, the carbonyl group acts as an electron-
withdrawing group, which decreases the electron-rich-
ness of the conjugated alkene group. The combination 
of polarizable mobile electrons and the electron-with-
drawing capacity of the carbonyl group thus creates an 
area of electron deﬁ ciency at the alkene  β -carbon atom 
of the  α , β -unsaturated carbonyl derivatives [215]. 
Hence, the  β -carbon atom shows an electrophilic char-
acter, which in the case of  γ -hydroxylated derivatives, 
such as HNE and HHE is further enhanced by the induc-
tive eﬀ ect of the vicinal hydroxyl group. It covalently 
reacts with the nucleophilic (electron-rich species) side 
chains on amino acid residues of proteins, such as the 
thiol group of cysteine, the imidazolic nitrogen of histi-
dine, and the epsilon amino group of Lys, forming the 
corresponding Michael adduct. However, although the 
Michael adducts formed with Cys and His are stable in 
isolation, Michael adducts to Lys  ε -amino groups are 
formed reversibly and can be isolated only following 
reductive trapping with NaBH 4 [216,217]. If the result-
ing Michael adduct contains an  γ -hydroxyaldehyde, it 
can further react intra-molecularly forming cyclic hemi-
acetals (Figure 10). Another general reaction involving 
 α , β -unsaturated aldehydes consists of the reaction of the 
aldehydic carbonyl group with the primary amino group 
of Lys or with the terminal amino group, forming the 
corresponding Schiﬀ  base. In more detail, the reaction 
starts with the formation of a carbinolamine intermedi-
ate that rearranges and loses water to yield a Schiﬀ  base. 
It should be noted that the Schiﬀ  base is a reversible 
adduct which undergoes a hydrolytic cleavage and hence 
it is more stable when the reaction involves the Lys 
residues embedded in lipohilic and anhydrous 
protein pockets. Figure 10 (in particular the right side) 
summarizes the general reaction mechanisms for hydrox-
ylated and nonhydroxylated  α , β -unsaturated aldehydes. 
 The Michael adducts and Schiﬀ  bases are the early 
reaction products of  α , β -unsaturated carbonyl that for 
most of the RCS further react and rearrange forming addi-
tional reaction products such as cross-links and which are 
speciﬁ c for each RCS. 
 For example, the left side of Figure 10 shows that HNE 
(one of the most abundant and reactive lipid-derived 
RCS, generated through the  β -cleavage of hydroperoxides 
from PUFAs containing  ω -six chains, such as linoleic 
acid and arachidonic acid,  13.6 ) [218], besides forming 
Michael adduct reaction products with His, Cys, and Lys 
residues as well as Schiﬀ  bases with Lys residues, also 
forms other diﬀ erent ALEs, such as the HNE-derived 
2-pentylpyrroles ( 10.1 ) and the ﬂ uorescent four-electron 
oxidation product, 2-hydroxy-2-pentyl-1,2-dihydropyr-
rol-3-one iminium ( 10.2 ) [219]. HNE, since possessing 
both an aldehyde and an electrophilic carbon, can form 
cross-links, involving condensation with Lys at carbonyl 
carbon atom (Schiﬀ  base) and the Michael adduct at 
 β -carbon atom with nucleophilic residues ( 10.3 ). This 
adduct can then dehydrate yielding the cyclic car-
binolamine ( 10.4 ) [220]. 
 The 4-keto derivative of HNE, 4-oxo-nonenal (ONE, 
 9.6 ), has been demonstrated to be a direct product of 
lipid oxidation [221,222], arising independently and 
not from oxidation of HNE, and more reactive that HNE 
(it reacts with protein nucleophiles through conjugate 
addition at a rate 6 – 31 times faster than does HNE) 
[223]. As depicted in Figure 11, ONE forms simple 
4-ketoaldehyde Michael adducts by the reaction of C2 
( 11.1 ) and C3 ( 11.2 ) with His, Lys, and Cys that can 
exist as such or undergo ring-closure to furans ( 11.3 
and  11.4 ). Additionally, 4-ketoaldehyde adducts can 
react with Lys forming 2,3- and 2,4-disubsitututed pyr-
role cross-links ( 11.5 and  11.6 ) [224]. ONE reacts also 
with the amino group of Lys forming the corresponding 
Schiﬀ  base ( 11.7 ), which then reacts with a second 
amine moiety at C3, followed by tautomerization and 
then a second two-electron autoxidation to give the 
ﬂ uorophore pyrrolium Lys – Lys cross link ( 11.8 ) which 
is also formed by HNE. More recently Zhu and Sayre 
[225] reported that apparent long-lived Lys adducts 
with the mass expected of a Michael adduct are actually 
the isomeric 4-ketoamide ( 11.9 ) which together with 
Lys-derived pyrrolinone ( 11.10 ) and Lys – His imida-
zolyl pyrrole cross-links ( 11.5 or  11.6 with Nu    His) 
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are all major products that form on proteins from ONE. 
Notably, Lys-derived pyrrolinone ( 11.10 ) which is in 
equilibrium with its corresponding hydroxy pyrrole 
tautomer, can dimerize generating the 2:2 ONE-Lys 
adduct ( 11.11 ). It should be noted that unlike HNE and 
other  α , β -unsaturated aldehydes, ONE reacts also with 
Arg residues to give stable covalent adducts. Preference 
for the reaction of amino acid nucleophiles with ONE 
was determined to have the following order: Cys    His  
Lys   Arg [226]. 
 Another well-studied  α , β -unsaturated aldehyde is 
represented by ACR ( 9.4 ) which has several sources 
other than peroxidation of PUFAs including the metab-
olism of amino acids, polyamines and drugs as well as 
the environment and food [22]. Among the  α , β -unsatu-
rated aldehydes, ACR is by far the strongest electrophile 
and therefore shows the highest reactivity with protein 
nucleophiles, the order of reactivity (Cys   His   Lys) 
being the same as that established for HNE. As illus-
trated in Figure 12 and among these sites, the preferen-
tial formation of Michael-type adducts on cysteine 
residues ( 12.1 ) is believed to be the predominant way 
for ACR to exert its reactivity in biological systems. 
Besides a simple Michael adduct, ACR forms additional 
ALEs as studied by Uchida et  al. In particular they iden-
tiﬁ ed an ACR – lysine adduct, N ε -(3-formyl-3,4-dehy-
dropiperidino)lysine (FDP-lysine, 12.4). The mechanism 
proposed for FDP-Lys formation involves Michael addi-
tion of the Lys amino group to the ACR  β -carbon atom 
to give a secondary amine with retention of the aldehyde 
group ( 12.3 ). This intermediate reacts with another ACR 
molecule via a Michael addition forming a derivative 
( 12.5 ) that, after aldol condensation and dehydration, 
gives the FDP-Lys adduct [227]. Later Uchida et  al. 
identiﬁ ed another ACR-dependent ALE, the N ε -(3-
methylpyridinium)-lysine (MP-lysine,  12.6 ), resulting 
from the initial Schiﬀ  base formation of ACR with the 
 ε -amino group of lysine, which further reacts with a 
second ACR molecule via a Michael addition to gener-
ate an imine derivative. The subsequent conversion of 
this imine derivative to the ﬁ nal product (MP-lysine, 
 12.8 ) requires two oxidation steps and intramolecular 
cyclization, but its detailed mechanism has not yet been 
clariﬁ ed [228]. 
 More recently the same research group, by using a 
reductive amination-based pyridylamination method, 
analyzed the ACR-speciﬁ c adducts with a carbonyl func-
tion and found that ACR modiﬁ cation of the protein pro-
duced a number of carbonylated amino acids, including 
an ACR    histidine adduct. On the basis of the chemical 
and spectroscopic evidence, this adduct was identiﬁ ed as 
N τ -(3-propanal)histidine ( 12.2 ) which appeared to be one 
of the major adducts generated in the oxidized LDL 
[229]. 
 Figure 10. General reaction mechanisms of ALEs formation for hydroxylated and nonhydroxylated  α , β -unsaturated aldehydes with speciﬁ c 
focus to HNE-derived ALEs. 
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 Dicarbonyls 
 Exogenous and endogenous sources 
 The diverse sources of glyoxal and methylglyoxal have 
already been described in the previous sections and here 
attention is focused on those of malodialdeyde and 
isoketals. The former has endogenous sources almost 
identical to those of  α , β -unsaturated carbonyls since its 
main  in vivo source is represented by peroxidation of 
poly unsaturated fatty acids with two or more methylene-
interrupted double bonds [230]. Isoketals, also called 
LGs and isolevuglandins (isoLGs), are formed by the 
rearrangement of endoperoxide intermediates generated 
through the cyclooxygenase and free radical-induced 
oxidation of arachidonates [231]. In detail, the endoper-
oxide intermediate undergoes a 1,2-hydride shift during 
the cleavage of three bonds in a concerted fashion with 
a polarized transition state. This reaction yields two 
 γ -ketoaldehydes, namely levuglandin E2 (LGE2) and 
levuglandin D2 (LGD2) which are derivatives of levu-
linaldehyde with prostanoid side chains and which read-
ily undergo dehydration leading to their anhydro analogs 
(AnLGE2 and AnLGD2) [232,233]. As mentioned 
before, the endoperoxide intermediate can be generated 
enzymatically through cyclooxygenase which adds two 
molecules of oxygen to a molecule of arachidonic acid 
to produce prostaglandin endoperoxide G2 (PGG2) as 
well as nonenzymatically by a free radical peroxidative 
mechanism as demonstrated by the observation that 
these isoprostanoids are generated  in vivo , even after 
application of cyclooxygenase inhibitors [234]. 
 While isoketals are generated almost only endoge-
nously, malondialdeyde can be present in foods arising 
from lipid peroxidation induced by heating. Indeed, it has 
been found in heated edible oils such as sunﬂ ower and 
palm oils and is contained at high levels in many rancid 
foods [235]. 
 ALEs formed by di-carbonyls 
 Diﬀ erent ALEs are generated by the reaction of di-
carbonyls (di-aldehydes and cheto-aldehydes) with pro-
teins. Some of these RCS, such as GO and MGO, besides 
being generated by a lipid oxidation/metabolism, are also 
formed by diﬀ erent enzymatic and nonenzymatic path-
ways involving sugars and their reactivity and formation 
of AGEs adducts have already been discussed under the 
AGEs section. 
 It should ﬁ rstly be noted that the ability of the di-
carbonyls to form stable and irreversible ALEs in rela-
tively short periods is due to the presence of both the 
 Figure 11. Reaction mechanisms of formation for the ONE-based adducts with nucleophilic sites. Adapted from [22]. 
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electron-withdrawing carbonyl groups, the chemical reac-
tivity of which is further enhanced by the activation of 
one carbonyl group on the other. Indeed, the presence of 
only one carbonyl function can only give reversible Schiﬀ  
bases that to be analytically detected require stabilization 
by a chemical reduction (reductive amination) using, for 
example, sodium borohydride. 
 The reaction of the lipid-derived di-carbonyls usually 
involves the formation of a carbinolamine as a ﬁ rst step, 
followed by diﬀ erent rearrangement reactions leading to, 
in most cases, heterocylic cross-links as above reported 
in the cases of glyoxal and methylglyoxal. Isoketals is 
another example of di-carbonyls forming irreversible 
ALEs, which include heterocyclic cross-links. Isoketals 
are highly reactive  γ -ketoaldehydes formed by free 
radical-mediated lipid peroxidation of H2-isoprostanes. 
Unlike the F2-isoprostanes, the biological eﬀ ect of these 
products is due to their ability to modify proteins rather 
than through activation of speciﬁ c receptors [234]. 
Figure 13 reports the reaction of isoketals ( 13.1 ) with 
the amino group of Lys which is based on the formation 
of a carbinolamine intermediate ( 13.2 ) that is in equi-
librium with the corresponding reversible Schiﬀ  base 
( 13.3 ) or the remaining carbonyl of hemiaminal can 
 Figure 13. Reaction mechanisms of formation for the isoketal-based adducts with nucleophilic sites. 
 Figure 12. Reaction mechanisms of formation for the acrolein-based adducts with nucleophilic sites. 
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undergo an intramolecular nucleophilic attack by the 
 ε - amino group of a second Lys residue to yield a highly 
unstable pyrrolidine adduct ( 12.4 ) which undergoes a 
rapid dehydration to form a pyrrole adduct ( 12.5) 
[232]. 
 Malondialdehyde ( 9.5 , MDA) is often the most abun-
dant individual aldehyde resulting from lipid peroxida-
tion and occurs in biological materials in various 
covalently bound forms [218]. As shown in Figure 14 and 
compared with other RCS, MDA is relatively less reactive 
at neutral pH and this is explained by considering that it 
enolizes rapidly and then loses a proton at neutral pH 
forming the enolate salt ( 14.2 ) which is stabilized by a 
conjugated  π -bond system. The reactivity of MDA is due 
to the nondissociated enolate (the  β -hydroxyacrolein, 
 14.1 ) which is able to react with the  ε -amino group of 
Lys forming the semistable N ε -(2-propenal)lysine (N-pro-
penal-Lys,  14.3 ). N-propenal-Lys can further react with 
another molecule of MDA and a molecule of acetalde-
hyde (derived from MDA breakdown) to form a stable 
ﬂ uorescent product containing a dihydropyridine moiety 
(DHP-Lys,  14.4 ) or with an additional Lys residue to form 
a Lys – Lys-diimine ( 14.5 ) which would exist as its reso-
nance-stabilized enamine ( 14.6 , Figure 14) [236]. The 
aldehyde side chains on the stable dihydropyridine ring 
can further react with Lys residues to form a reversible 
cross-link [237]. MDA protein adducts and, in particular, 
N-propenal-Lys and the dihydropyridine cross-links have 
been more recently characterized by MS approaches and 
using insulin and albumin as target proteins [238,239]. 
Beside Lys, MDA reacts with other nucleophilic residues 
such as Arg forming the stable N δ -(2-pirimidyl)-L-
ornitine ( 14.7 ) [240]. Cross-linking of MDA involving 
Lys and Arg residues, 2-ornithinyl-4-methyl(1 ϵ -lysyl)
1,3-imidazole ( 14.8 ), has been elucidated by NMR and 
MS and identiﬁ ed in diabetic patients [241]. 
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